AbstractObjectivesThis study is to report a case of hypersensitivity vasculitis with petechiae improved by Jeoryoung-tang
MethodsPetechiae was observed in the upper and lower extremities of the patient. The patient also complained of cystitis symptoms such as dysuria and residual urine. Since there were no other accompanying symptoms such as abdominal pain, bleeding, or joint pain, the patient was diagnosed with hypersensitivity vasculitis and Jeoryoung-tang was prescribed for about a month.
ResultsAfter administering Jeoryoung-tang for about a month, petechiae improved from 8 to 2 points, and cystitis symptoms also improved from NRS 7 to 2 points.
ConclusionsSince it has been confirmed that Jeoryoung-tang was effective as the treatment of skin symptoms through this case, Jeoryoung-tang can be prescribed for patients with other type skin diseases. However, since it is difficult to generalize this single case, continuous follow-up studies should be conducted.
참고문헌1. Kwon, KY. (2008). Diagnosis and treatment of purpura. The Korean Journal of Medicine, 75(2), 169-72.
2. Traditional Korean Dermatology & Surgery Textbook Compilation Committee. 2007. Text of traditional Korean dermatology & surgery. 1st ed. Busan: Sunwoo;463-6.
3. Kim, JS, Choi, JH, Kim, JH, Jeong, MY, & Park, SY. (2016). A case of allergic purpura treated with Korean medicine-two cases. Herb Formula Sci, 24(1), 63-70.
4. Kang, DW, Park, JG, Han, CY, Kim, KS, & Kim, YB. (2019). Review of Korean medicine treatments for purpura and vasculitis in Korean journals. J Korean Med Ophthalmol Otolaryngol Dermatol, 32(3), 116-35.
5. Mang WJ. (1996). Sanghanron commentary. 1st ed. Iksan. Wonkwang University Press Office;p. 297-9.
6. Kim, BM, & Jo, HG. (2020). Adjuvant therapy efficacy of herbal medicine Zeo Lyung Tang (Zhu Ling Decoction) for primary glomerulonephritis: Systemic review and meta-analysis. J Int Korean Med, 41(4), 633-57.
7. Lee, CR, Kim, TH, Rhee, JW, Na, BJ, Kim, EJ, & Lee, SH, et al. (2003). Case studies on the patients with urinary tract infection after stroke treated with Oryeong-san Gamibang(Wuring-san Jiaweifang). J Int Korean Med, 168-75.
8. Zufferey, A, Kapur, R, & Semple, JW. (2017). Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med, 6(2), 16.
9. Choi, KC. (2001). Idiopathic thrombocytopenic purpura. Journal of the Korean Pediatric Society, 44(2), 115-8.
10. Kwon, JM, & Pak, KY. (2018). Poor prognosis in idiopathic thrombocytopenic purpura-associated retinopathy. J Korean Ophthalmol Soc, 59(4), 384-7.
|
|